[go: up one dir, main page]

NO20013891L - Sammensetninger omfattende citalopram - Google Patents

Sammensetninger omfattende citalopram

Info

Publication number
NO20013891L
NO20013891L NO20013891A NO20013891A NO20013891L NO 20013891 L NO20013891 L NO 20013891L NO 20013891 A NO20013891 A NO 20013891A NO 20013891 A NO20013891 A NO 20013891A NO 20013891 L NO20013891 L NO 20013891L
Authority
NO
Norway
Prior art keywords
citalopram
pharmaceutically acceptable
mixture
compositions
acceptable salt
Prior art date
Application number
NO20013891A
Other languages
English (en)
Norwegian (no)
Other versions
NO20013891D0 (no
Inventor
Ken Liljegren
Per Holm
Ole Nielsen
Swen Wagner
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26068858&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20013891(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of NO20013891D0 publication Critical patent/NO20013891D0/no
Publication of NO20013891L publication Critical patent/NO20013891L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20013891A 2000-08-10 2001-08-09 Sammensetninger omfattende citalopram NO20013891L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200001202 2000-08-10
DKPA200001614 2000-10-27

Publications (2)

Publication Number Publication Date
NO20013891D0 NO20013891D0 (no) 2001-08-09
NO20013891L true NO20013891L (no) 2002-02-11

Family

ID=26068858

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20013891A NO20013891L (no) 2000-08-10 2001-08-09 Sammensetninger omfattende citalopram

Country Status (34)

Country Link
EP (1) EP1318805A2 (sk)
JP (1) JP2003531153A (sk)
KR (1) KR20030024833A (sk)
CN (1) CN1446089A (sk)
AR (1) AR030095A1 (sk)
AT (1) AT5744U1 (sk)
AU (2) AU2001100198B4 (sk)
BE (1) BE1013559A6 (sk)
BG (1) BG107578A (sk)
BR (1) BR0113250A (sk)
CA (1) CA2353693C (sk)
CH (2) CH694241A5 (sk)
CZ (1) CZ2003397A3 (sk)
DE (2) DE10139115A1 (sk)
EA (1) EA200300247A1 (sk)
ES (1) ES2172481B2 (sk)
FI (1) FI5176U1 (sk)
FR (1) FR2812811B1 (sk)
GB (1) GB2368014B (sk)
GR (1) GR1004193B (sk)
HR (1) HRP20030054A2 (sk)
HU (1) HUP0103071A3 (sk)
IE (1) IES20010693A2 (sk)
IL (1) IL154050A0 (sk)
IS (1) IS6021A (sk)
IT (1) ITMI20011637A1 (sk)
MX (1) MXPA03000837A (sk)
NL (1) NL1018741C1 (sk)
NO (1) NO20013891L (sk)
NZ (1) NZ523785A (sk)
PL (1) PL359824A1 (sk)
SK (1) SK2842003A3 (sk)
WO (1) WO2001080619A2 (sk)
YU (1) YU9003A (sk)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IES20010693A2 (en) * 2000-08-10 2002-07-10 Lundbeck & Co As H Pharmaceutical composition containing citalopram
AU2001100195B4 (en) * 2001-01-05 2001-12-20 H Lundbeck As Pharmaceutical composition containing citalopram.
GB0206708D0 (en) * 2002-03-21 2002-05-01 Cipla Ltd Pharmaceutical salts
US6812355B2 (en) 2002-10-22 2004-11-02 Sekhsaria Chemicals Limited Process for the manufacture of citalopram hydrobromide from 5-bromophthalide
BR0317623A (pt) * 2002-12-23 2005-11-29 Lundbeck & Co As H Escitalopram, composição farmacêutica, e, uso de hidrobrometo de escitalopram
WO2004103361A2 (en) * 2003-05-20 2004-12-02 Ranbaxy Laboratories Limited A pharmaceutical dosage form of citalopram
HU227491B1 (en) * 2003-11-25 2011-07-28 Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag Tablet containing citalopram hydrogen bromide
WO2006038217A1 (en) * 2004-10-05 2006-04-13 Strides Acrolab Limited An improved drug delivery system of citalopram hydrobromide and process for producing the same
US7834201B2 (en) 2005-06-22 2010-11-16 H. Lundbeck A/S Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
CN100353939C (zh) * 2006-01-05 2007-12-12 昆明积大制药有限公司 含西酞普兰和环糊精的抗抑郁口服药用组合物
GB2446847B (en) * 2007-02-02 2012-02-22 Ubiquisys Ltd Location of Basestation
CN106397248A (zh) * 2015-08-03 2017-02-15 深圳信立泰药业股份有限公司 一种lcz696结晶粉末及其制备方法
EP4277661A1 (en) * 2021-01-18 2023-11-22 Anton Frenkel Pharmaceutical dosage form
EP4661849A1 (en) 2023-02-07 2025-12-17 Kinast, Lasse An immediate-release oral pharmaceutical form of escitalopram or racemate thereof with increased api content

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1358915A (en) * 1919-04-14 1920-11-16 Amici Domenico Aeroplane
GB1358915A (en) * 1971-09-13 1974-07-03 Merck & Co Inc Directly compressed tablet and composition therefor
GB1526331A (en) 1976-01-14 1978-09-27 Kefalas As Phthalanes
GB8419963D0 (en) 1984-08-06 1984-09-12 Lundbeck & Co As H Intermediate compound and method
GB8814057D0 (en) * 1988-06-14 1988-07-20 Lundbeck & Co As H New enantiomers & their isolation
US5296507A (en) * 1990-09-06 1994-03-22 H.Lundbeck A/S Treatment of cerbrovascular disorders
EP0714663A3 (en) * 1994-11-28 1997-01-15 Lilly Co Eli Potentiation of drug responses by serotonin 1A receptor antagonists
GB9714841D0 (en) * 1997-07-14 1997-09-17 Smithkline Beecham Plc Treatment method
GB2357762B (en) * 2000-03-13 2002-01-30 Lundbeck & Co As H Crystalline base of citalopram
US6977306B2 (en) 2000-05-02 2005-12-20 Sumitomo Chemical Company, Limited Citalopram hydrobromide crystal and method for crystallization thereof
IES20010693A2 (en) * 2000-08-10 2002-07-10 Lundbeck & Co As H Pharmaceutical composition containing citalopram

Also Published As

Publication number Publication date
KR20030024833A (ko) 2003-03-26
IL154050A0 (en) 2003-07-31
AR030095A1 (es) 2003-08-13
CH694241A5 (de) 2004-10-15
BE1013559A6 (fr) 2002-03-05
NZ523785A (en) 2004-09-24
HRP20030054A2 (en) 2005-02-28
JP2003531153A (ja) 2003-10-21
EP1318805A2 (en) 2003-06-18
GR1004193B (el) 2003-03-24
NL1018741C1 (nl) 2002-02-12
ITMI20011637A0 (it) 2001-07-27
DE10139115A1 (de) 2002-03-28
YU9003A (sh) 2006-05-25
HUP0103071A3 (en) 2002-12-28
HUP0103071A2 (hu) 2002-05-29
CH694242A5 (de) 2004-10-15
DE20113195U1 (de) 2001-11-15
ITMI20011637A1 (it) 2003-01-27
GB2368014A (en) 2002-04-24
ES2172481B2 (es) 2004-08-01
WO2001080619A3 (en) 2002-02-21
GB2368014B (en) 2004-06-23
IES20010693A2 (en) 2002-07-10
GR20010100377A (el) 2002-09-06
BR0113250A (pt) 2003-06-24
CA2353693C (en) 2003-07-22
AU2001279591A1 (en) 2001-11-07
IS6021A (is) 2001-10-20
SK2842003A3 (en) 2003-09-11
CA2353693A1 (en) 2002-01-22
AT5744U1 (de) 2002-11-25
AU2001100198A4 (en) 2001-08-16
FI5176U1 (fi) 2001-12-27
CZ2003397A3 (cs) 2003-06-18
ES2172481A1 (es) 2002-09-16
GB0118579D0 (en) 2001-09-19
PL359824A1 (en) 2004-09-06
EA200300247A1 (ru) 2003-06-26
NO20013891D0 (no) 2001-08-09
AU2001100198B4 (en) 2002-06-13
FR2812811A1 (fr) 2002-02-15
CN1446089A (zh) 2003-10-01
BG107578A (bg) 2003-09-30
FR2812811B1 (fr) 2006-08-18
HU0103071D0 (en) 2001-10-28
MXPA03000837A (es) 2003-06-06
WO2001080619A2 (en) 2001-11-01

Similar Documents

Publication Publication Date Title
NO20013891L (no) Sammensetninger omfattende citalopram
EA200300873A1 (ru) Новая соль сукцинат o-десметилвенлафаксина
NO20040794L (no) (-)-1-(3,4-Diklorfenyl)-3-azabicyklo[3.1.0]heksan, forbindelser derav og anvendelser som en dopamin-gjenopptaks-inhibitor.
NO20071498L (no) Substituerte acylhydroksamsyrer samt fremgangsmate for a redusere TNFa-nivaet
EA200300104A1 (ru) НОВАЯ γ КРИСТАЛЛИЧЕСКАЯ ФОРМА ТРЕТ-БУТИЛАМИНОВОЙ СОЛИ ПЕРИНДОПРИЛА, СПОСОБ ЕЕ ПОЛУЧЕНИЯ И СОДЕРЖАЩИЕ ЕЕ ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ
ES2165833T1 (es) Composicion farmaceutica revestida enterica y procedimiento de fabricacion.
EA200200147A1 (ru) Фармацевтическая композиция, содержащая фенофибрат, и способ ее получения
AR010634A1 (es) Composicion farmaceutica en forma de una solucion para la administracion de inhibidores de proteasa hiv
NO20013254L (no) Nye difenylureaforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske samensetninger som inneholder dem
IS3659A7 (is) Ný aðferð við að framleiða útskipt 4-fenýl-4-píperídínkarboxamíð sem hefur bæði staðbundin deyfandi og kvalastillandi áhrif
WO2004093800A3 (en) Thyronamine derivatives and analogs and methods of use thereof
KR850001693A (ko) 아모술랄롤 하이드로클로라이드 지속성 제제의 제조방법
EE05085B1 (et) Pridiin-1-oksiidderivaat ja meetod selle muutmiseks farmatseutiliselt efektiivseteks henditeks
NO20043834L (no) Farmasoytisk sammensetning omfattende N-((1-N-butyl-4-piperidinyl)metyl-3,4-dihydro-2H-(1,3)-oksazino(3,2-A)indol-l0-karboksyamid eller salter og fremgangsmate derfor omfattende torr granulering
EA200401067A1 (ru) Раствор ибупрофена для капсул с твердыми оболочками
AR038143A1 (es) Agonistas del receptor 2 del factor liberador de la corticotropina
AR042652A1 (es) Bromhidrato de escitalopram y un metodo para su preparacion
NO20004919D0 (no) FremgangsmÕte for fremstilling av 5-hydroksybenzo[b]tiofen-3- karboksylsyrederivater
NO944214L (no) Farmasöytiske preparater for rektal administrering, inneholdende alkylsulfonamider som er HT1-agonister
KR930012018A (ko) 약제학적 조성물
EA200201003A1 (ru) Аморфная модификация торасемида
HUP9902559A2 (hu) Paracetamolt és drotavenint tartalmazó gyógyszerkészítmény és eljárás előállítására
NO20060313L (no) Saquinavirmesylat oral doseringsform
EA200300768A1 (ru) Фармацевтическая композиция, содержащая циталопрам
SE0200256D0 (sv) New composition, methods and use

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application